UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by McKinley Carter Wealth Services Inc.

McKinley Carter Wealth Services Inc. lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,081 shares of the healthcare conglomerate’s stock after selling 205 shares during the period. McKinley Carter Wealth Services Inc.’s holdings in UnitedHealth Group were worth $9,652,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Invst LLC grew its holdings in UnitedHealth Group by 20.0% during the 2nd quarter. Invst LLC now owns 1,510 shares of the healthcare conglomerate’s stock worth $747,000 after acquiring an additional 252 shares in the last quarter. Quarry LP increased its holdings in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 37 shares during the last quarter. Gateway Wealth Partners LLC lifted its holdings in UnitedHealth Group by 34.9% during the 2nd quarter. Gateway Wealth Partners LLC now owns 1,211 shares of the healthcare conglomerate’s stock worth $617,000 after buying an additional 313 shares during the last quarter. Pathway Financial Advisers LLC increased its holdings in shares of UnitedHealth Group by 3.5% in the 2nd quarter. Pathway Financial Advisers LLC now owns 6,718 shares of the healthcare conglomerate’s stock valued at $3,372,000 after acquiring an additional 230 shares during the last quarter. Finally, Truist Financial Corp lifted its stake in UnitedHealth Group by 46.7% during the second quarter. Truist Financial Corp now owns 898,406 shares of the healthcare conglomerate’s stock worth $457,522,000 after purchasing an additional 286,122 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $542.52 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market cap of $499.27 billion, a P/E ratio of 35.00, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. The business has a fifty day moving average of $539.43 and a two-hundred day moving average of $565.28.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business posted $5.83 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In related news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.